Hua Medicine Ltd. announced that it has received $25 million in funding from group of investors.
January 08, 2015 at 09:30 am IST
Hua Medicine Ltd. announced that it has received $25 million in its series B round of funding led by new investor Ally Bridge Group on January 8, 2015. The transaction includes participation from other new investors, Frontline BioVentures, TF Capital, and existing investors, Arch Venture Partners, L.P., Venrock, Fidelity Biosciences, WuXi Healthcare Ventures, and SAIL Capital Partners LLC.
On January 8, 2015, Hua Medicine Ltd. closed the transaction.